Viewing Study NCT03277456


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-03-04 @ 9:54 PM
Study NCT ID: NCT03277456
Status: COMPLETED
Last Update Posted: 2017-11-14
First Post: 2017-09-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1
Sponsor: Barinthus Biotherapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module